From R&D Investment to Externalization: Where is the Pharma Industry Maximizing Value?

From R&D Investment to Externalization: Where is the Pharma Industry Maximizing Value?

  • June 2017 •
  • 51 pages •
  • Report ID: 5182414 •
  • Format: PDF
Overview
Pharmaceutical companies are attempting to maximize value from all angles, including internal investment in R&D and externalization via deal-making. The growth in these two models has had an impact on both revenue derived from internally developed products, as well as externalized drugs.
This report is a written adaptation of a webinar presented in May 2017 by Datamonitor Healthcare titled “From R&D Investment to Externalization: Where is the Pharma Industry Maximizing Value?".